Ionic Capital Management’s Eyegate Pharmaceuticals, Inc. Warrants EYEGW Stock Holding History

Ionic Capital Management’s Portfolio EYEGW Stock Details EYEGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-133,097	Closed	-$20K	–	367
2017 Q1	$20K	Sell	133,097 -18,176	-12%	-$4.35K	﹤0.01%	291
2016 Q4	$53K	Sell	151,273 -1,500	-1%	-$590	﹤0.01%	331
2016 Q3	$53K	Hold	152,773	–	–	﹤0.01%	353
2016 Q2	$5K	Hold	152,773	–	–	﹤0.01%	312
2016 Q1	$115K	Sell	152,773 -5,500	-3%	-$3.81K	0.01%	259
2015 Q4	$119K	Buy	158,273 +130,400	+468%	+$109K	0.01%	290
2015 Q3	$24K	Buy	+27,873	New	+$34.4K	﹤0.01%	287

Other funds holding EYEGW

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ionic Capital Management's EYEGW Position: Q2 2017 in Review

Ionic Capital Management sold out of Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) in Q2 2017, closing a stake of 133,097 shares — an estimated $20K sold.

Ionic Capital Management first reported a position in EYEGW in Q3 2015 and held it in 7 quarters. The position peaked at $119K in Q4 2015. 4 funds tracked by Wall St. Rank hold EYEGW as of Q2 2017.

Ionic Capital Management reported no remaining Eyegate Pharmaceuticals, Inc. Warrants position as of Q2 2017 after selling out during the quarter.
Ionic Capital Management sold 133,097 Eyegate Pharmaceuticals, Inc. Warrants shares in Q2 2017, an estimated $20K.
Ionic Capital Management first reported a position in Eyegate Pharmaceuticals, Inc. Warrants in Q3 2015 and held it in 7 quarters.
Ionic Capital Management's Eyegate Pharmaceuticals, Inc. Warrants position peaked at $119K in Q4 2015.
4 funds tracked by Wall St. Rank held Eyegate Pharmaceuticals, Inc. Warrants as of Q2 2017.

Based on Ionic Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.